Report cover image

Global Erectile Dysfunction Drugs Market Analysis and Forecast 2025-2031

Publisher APO Research, Inc.
Published Aug 16, 2025
Length 198 Pages
SKU # APRC20362492

Description

Summary

According to APO Research, The global Erectile Dysfunction Drugs market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Erectile Dysfunction Drugs is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Erectile Dysfunction Drugs is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The China market for Erectile Dysfunction Drugs is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Erectile Dysfunction Drugs is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Erectile Dysfunction Drugs include Eli Lilly, Pfizer, Bayer, BaiYunShan General Factory, Teva Pharma, Seoul Pharma, S.K. Chemicals, Petros Pharmaceuticals and Dong-A ST, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Erectile Dysfunction Drugs, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020 - 2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Erectile Dysfunction Drugs, also provides the sales of main regions and countries. Of the upcoming market potential for Erectile Dysfunction Drugs, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Erectile Dysfunction Drugs sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Erectile Dysfunction Drugs market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Erectile Dysfunction Drugs sales, projected growth trends, production technology, application and end-user industry.

Erectile Dysfunction Drugs Segment by Company

Eli Lilly
Pfizer
Bayer
BaiYunShan General Factory
Teva Pharma
Seoul Pharma
S.K. Chemicals
Petros Pharmaceuticals
Dong-A ST
CSBIO.
Erectile Dysfunction Drugs Segment by Type

Sildenafil
Tadalafil
Others
Erectile Dysfunction Drugs Segment by Application

E-Commerce (B2B)
E-Commerce (B2C)
Retail Pharmacies
Private Clinics
Hospital Pharmacies
Erectile Dysfunction Drugs Segment by Region

North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Erectile Dysfunction Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Erectile Dysfunction Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Erectile Dysfunction Drugs.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of Erectile Dysfunction Drugs in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Erectile Dysfunction Drugs manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Erectile Dysfunction Drugs sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.

Table of Contents

198 Pages
1 Market Overview
1.1 Product Definition
1.2 Erectile Dysfunction Drugs Market by Type
1.2.1 Global Erectile Dysfunction Drugs Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Sildenafil
1.2.3 Tadalafil
1.2.4 Others
1.3 Erectile Dysfunction Drugs Market by Application
1.3.1 Global Erectile Dysfunction Drugs Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 E-Commerce (B2B)
1.3.3 E-Commerce (B2C)
1.3.4 Retail Pharmacies
1.3.5 Private Clinics
1.3.6 Hospital Pharmacies
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 Erectile Dysfunction Drugs Market Dynamics
2.1 Erectile Dysfunction Drugs Industry Trends
2.2 Erectile Dysfunction Drugs Industry Drivers
2.3 Erectile Dysfunction Drugs Industry Opportunities and Challenges
2.4 Erectile Dysfunction Drugs Industry Restraints
3 Global Market Growth Prospects
3.1 Global Erectile Dysfunction Drugs Revenue Estimates and Forecasts (2020-2031)
3.2 Global Erectile Dysfunction Drugs Revenue by Region
3.2.1 Global Erectile Dysfunction Drugs Revenue by Region: 2020 VS 2024 VS 2031
3.2.2 Global Erectile Dysfunction Drugs Revenue by Region (2020-2025)
3.2.3 Global Erectile Dysfunction Drugs Revenue by Region (2026-2031)
3.2.4 Global Erectile Dysfunction Drugs Revenue Market Share by Region (2020-2031)
3.3 Global Erectile Dysfunction Drugs Sales Estimates and Forecasts 2020-2031
3.4 Global Erectile Dysfunction Drugs Sales by Region
3.4.1 Global Erectile Dysfunction Drugs Sales by Region: 2020 VS 2024 VS 2031
3.4.2 Global Erectile Dysfunction Drugs Sales by Region (2020-2025)
3.4.3 Global Erectile Dysfunction Drugs Sales by Region (2026-2031)
3.4.4 Global Erectile Dysfunction Drugs Sales Market Share by Region (2020-2031)
3.5 US & Canada & Mexico
3.6 Europe
3.7 China
3.8 Asia (Excluding China)
3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
4.1 Global Erectile Dysfunction Drugs Revenue by Manufacturers
4.1.1 Global Erectile Dysfunction Drugs Revenue by Manufacturers (2020-2025)
4.1.2 Global Erectile Dysfunction Drugs Revenue Market Share by Manufacturers (2020-2025)
4.1.3 Global Erectile Dysfunction Drugs Manufacturers Revenue Share Top 10 and Top 5 in 2024
4.2 Global Erectile Dysfunction Drugs Sales by Manufacturers
4.2.1 Global Erectile Dysfunction Drugs Sales by Manufacturers (2020-2025)
4.2.2 Global Erectile Dysfunction Drugs Sales Market Share by Manufacturers (2020-2025)
4.2.3 Global Erectile Dysfunction Drugs Manufacturers Sales Share Top 10 and Top 5 in 2024
4.3 Global Erectile Dysfunction Drugs Sales Price by Manufacturers (2020-2025)
4.4 Global Erectile Dysfunction Drugs Key Manufacturers Ranking, 2023 VS 2024 VS 2025
4.5 Global Erectile Dysfunction Drugs Key Manufacturers Manufacturing Sites & Headquarters
4.6 Global Erectile Dysfunction Drugs Manufacturers, Product Type & Application
4.7 Global Erectile Dysfunction Drugs Manufacturers' Establishment Date
4.8 Market Competitive Analysis
4.8.1 Global Erectile Dysfunction Drugs Market CR5 and HHI
4.8.2 2024 Erectile Dysfunction Drugs Tier 1, Tier 2, and Tier 3
5 Erectile Dysfunction Drugs Market by Type
5.1 Global Erectile Dysfunction Drugs Revenue by Type
5.1.1 Global Erectile Dysfunction Drugs Revenue by Type (2020 VS 2024 VS 2031)
5.1.2 Global Erectile Dysfunction Drugs Revenue by Type (2020-2031) & (US$ Million)
5.1.3 Global Erectile Dysfunction Drugs Revenue Market Share by Type (2020-2031)
5.2 Global Erectile Dysfunction Drugs Sales by Type
5.2.1 Global Erectile Dysfunction Drugs Sales by Type (2020 VS 2024 VS 2031)
5.2.2 Global Erectile Dysfunction Drugs Sales by Type (2020-2031) & (M Pcs)
5.2.3 Global Erectile Dysfunction Drugs Sales Market Share by Type (2020-2031)
5.3 Global Erectile Dysfunction Drugs Price by Type
6 Erectile Dysfunction Drugs Market by Application
6.1 Global Erectile Dysfunction Drugs Revenue by Application
6.1.1 Global Erectile Dysfunction Drugs Revenue by Application (2020 VS 2024 VS 2031)
6.1.2 Global Erectile Dysfunction Drugs Revenue by Application (2020-2031) & (US$ Million)
6.1.3 Global Erectile Dysfunction Drugs Revenue Market Share by Application (2020-2031)
6.2 Global Erectile Dysfunction Drugs Sales by Application
6.2.1 Global Erectile Dysfunction Drugs Sales by Application (2020 VS 2024 VS 2031)
6.2.2 Global Erectile Dysfunction Drugs Sales by Application (2020-2031) & (M Pcs)
6.2.3 Global Erectile Dysfunction Drugs Sales Market Share by Application (2020-2031)
6.3 Global Erectile Dysfunction Drugs Price by Application
7 Company Profiles
7.1 Eli Lilly
7.1.1 Eli Lilly Comapny Information
7.1.2 Eli Lilly Business Overview
7.1.3 Eli Lilly Erectile Dysfunction Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
7.1.4 Eli Lilly Erectile Dysfunction Drugs Product Portfolio
7.1.5 Eli Lilly Recent Developments
7.2 Pfizer
7.2.1 Pfizer Comapny Information
7.2.2 Pfizer Business Overview
7.2.3 Pfizer Erectile Dysfunction Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
7.2.4 Pfizer Erectile Dysfunction Drugs Product Portfolio
7.2.5 Pfizer Recent Developments
7.3 Bayer
7.3.1 Bayer Comapny Information
7.3.2 Bayer Business Overview
7.3.3 Bayer Erectile Dysfunction Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
7.3.4 Bayer Erectile Dysfunction Drugs Product Portfolio
7.3.5 Bayer Recent Developments
7.4 BaiYunShan General Factory
7.4.1 BaiYunShan General Factory Comapny Information
7.4.2 BaiYunShan General Factory Business Overview
7.4.3 BaiYunShan General Factory Erectile Dysfunction Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
7.4.4 BaiYunShan General Factory Erectile Dysfunction Drugs Product Portfolio
7.4.5 BaiYunShan General Factory Recent Developments
7.5 Teva Pharma
7.5.1 Teva Pharma Comapny Information
7.5.2 Teva Pharma Business Overview
7.5.3 Teva Pharma Erectile Dysfunction Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
7.5.4 Teva Pharma Erectile Dysfunction Drugs Product Portfolio
7.5.5 Teva Pharma Recent Developments
7.6 Seoul Pharma
7.6.1 Seoul Pharma Comapny Information
7.6.2 Seoul Pharma Business Overview
7.6.3 Seoul Pharma Erectile Dysfunction Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
7.6.4 Seoul Pharma Erectile Dysfunction Drugs Product Portfolio
7.6.5 Seoul Pharma Recent Developments
7.7 S.K. Chemicals
7.7.1 S.K. Chemicals Comapny Information
7.7.2 S.K. Chemicals Business Overview
7.7.3 S.K. Chemicals Erectile Dysfunction Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
7.7.4 S.K. Chemicals Erectile Dysfunction Drugs Product Portfolio
7.7.5 S.K. Chemicals Recent Developments
7.8 Petros Pharmaceuticals
7.8.1 Petros Pharmaceuticals Comapny Information
7.8.2 Petros Pharmaceuticals Business Overview
7.8.3 Petros Pharmaceuticals Erectile Dysfunction Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
7.8.4 Petros Pharmaceuticals Erectile Dysfunction Drugs Product Portfolio
7.8.5 Petros Pharmaceuticals Recent Developments
7.9 Dong-A ST
7.9.1 Dong-A ST Comapny Information
7.9.2 Dong-A ST Business Overview
7.9.3 Dong-A ST Erectile Dysfunction Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
7.9.4 Dong-A ST Erectile Dysfunction Drugs Product Portfolio
7.9.5 Dong-A ST Recent Developments
7.10 CSBIO.
7.10.1 CSBIO. Comapny Information
7.10.2 CSBIO. Business Overview
7.10.3 CSBIO. Erectile Dysfunction Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
7.10.4 CSBIO. Erectile Dysfunction Drugs Product Portfolio
7.10.5 CSBIO. Recent Developments
8 North America
8.1 North America Erectile Dysfunction Drugs Market Size by Type
8.1.1 North America Erectile Dysfunction Drugs Revenue by Type (2020-2031)
8.1.2 North America Erectile Dysfunction Drugs Sales by Type (2020-2031)
8.1.3 North America Erectile Dysfunction Drugs Price by Type (2020-2031)
8.2 North America Erectile Dysfunction Drugs Market Size by Application
8.2.1 North America Erectile Dysfunction Drugs Revenue by Application (2020-2031)
8.2.2 North America Erectile Dysfunction Drugs Sales by Application (2020-2031)
8.2.3 North America Erectile Dysfunction Drugs Price by Application (2020-2031)
8.3 North America Erectile Dysfunction Drugs Market Size by Country
8.3.1 North America Erectile Dysfunction Drugs Revenue Grow Rate by Country (2020 VS 2024 VS 2031)
8.3.2 North America Erectile Dysfunction Drugs Sales by Country (2020 VS 2024 VS 2031)
8.3.3 North America Erectile Dysfunction Drugs Price by Country (2020-2031)
8.3.4 United States
8.3.5 Canada
9 Europe
9.1 Europe Erectile Dysfunction Drugs Market Size by Type
9.1.1 Europe Erectile Dysfunction Drugs Revenue by Type (2020-2031)
9.1.2 Europe Erectile Dysfunction Drugs Sales by Type (2020-2031)
9.1.3 Europe Erectile Dysfunction Drugs Price by Type (2020-2031)
9.2 Europe Erectile Dysfunction Drugs Market Size by Application
9.2.1 Europe Erectile Dysfunction Drugs Revenue by Application (2020-2031)
9.2.2 Europe Erectile Dysfunction Drugs Sales by Application (2020-2031)
9.2.3 Europe Erectile Dysfunction Drugs Price by Application (2020-2031)
9.3 Europe Erectile Dysfunction Drugs Market Size by Country
9.3.1 Europe Erectile Dysfunction Drugs Revenue Grow Rate by Country (2020 VS 2024 VS 2031)
9.3.2 Europe Erectile Dysfunction Drugs Sales by Country (2020 VS 2024 VS 2031)
9.3.3 Europe Erectile Dysfunction Drugs Price by Country (2020-2031)
9.3.4 Germany
9.3.5 France
9.3.6 U.K.
9.3.7 Italy
9.3.8 Netherlands
10 China
10.1 China Erectile Dysfunction Drugs Market Size by Type
10.1.1 China Erectile Dysfunction Drugs Revenue by Type (2020-2031)
10.1.2 China Erectile Dysfunction Drugs Sales by Type (2020-2031)
10.1.3 China Erectile Dysfunction Drugs Price by Type (2020-2031)
10.2 China Erectile Dysfunction Drugs Market Size by Application
10.2.1 China Erectile Dysfunction Drugs Revenue by Application (2020-2031)
10.2.2 China Erectile Dysfunction Drugs Sales by Application (2020-2031)
10.2.3 China Erectile Dysfunction Drugs Price by Application (2020-2031)
11 Asia (Excluding China)
11.1 Asia Erectile Dysfunction Drugs Market Size by Type
11.1.1 Asia Erectile Dysfunction Drugs Revenue by Type (2020-2031)
11.1.2 Asia Erectile Dysfunction Drugs Sales by Type (2020-2031)
11.1.3 Asia Erectile Dysfunction Drugs Price by Type (2020-2031)
11.2 Asia Erectile Dysfunction Drugs Market Size by Application
11.2.1 Asia Erectile Dysfunction Drugs Revenue by Application (2020-2031)
11.2.2 Asia Erectile Dysfunction Drugs Sales by Application (2020-2031)
11.2.3 Asia Erectile Dysfunction Drugs Price by Application (2020-2031)
11.3 Asia Erectile Dysfunction Drugs Market Size by Country
11.3.1 Asia Erectile Dysfunction Drugs Revenue Grow Rate by Country (2020 VS 2024 VS 2031)
11.3.2 Asia Erectile Dysfunction Drugs Sales by Country (2020 VS 2024 VS 2031)
11.3.3 Asia Erectile Dysfunction Drugs Price by Country (2020-2031)
11.3.4 Japan
11.3.5 South Korea
11.3.6 India
11.3.7 Australia
11.3.8 Taiwan
11.3.9 Southeast Asia
12 South America, Middle East and Africa
12.1 SAMEA Erectile Dysfunction Drugs Market Size by Type
12.1.1 SAMEA Erectile Dysfunction Drugs Revenue by Type (2020-2031)
12.1.2 SAMEA Erectile Dysfunction Drugs Sales by Type (2020-2031)
12.1.3 SAMEA Erectile Dysfunction Drugs Price by Type (2020-2031)
12.2 SAMEA Erectile Dysfunction Drugs Market Size by Application
12.2.1 SAMEA Erectile Dysfunction Drugs Revenue by Application (2020-2031)
12.2.2 SAMEA Erectile Dysfunction Drugs Sales by Application (2020-2031)
12.2.3 SAMEA Erectile Dysfunction Drugs Price by Application (2020-2031)
12.3 SAMEA Erectile Dysfunction Drugs Market Size by Country
12.3.1 SAMEA Erectile Dysfunction Drugs Revenue Grow Rate by Country (2020 VS 2024 VS 2031)
12.3.2 SAMEA Erectile Dysfunction Drugs Sales by Country (2020 VS 2024 VS 2031)
12.3.3 SAMEA Erectile Dysfunction Drugs Price by Country (2020-2031)
12.3.4 Brazil
12.3.5 Argentina
12.3.6 Chile
12.3.7 Colombia
12.3.8 Peru
12.3.9 Saudi Arabia
12.3.10 Israel
12.3.11 UAE
12.3.12 Turkey
12.3.13 Iran
12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
13.1 Erectile Dysfunction Drugs Value Chain Analysis
13.1.1 Erectile Dysfunction Drugs Key Raw Materials
13.1.2 Raw Materials Key Suppliers
13.1.3 Manufacturing Cost Structure
13.1.4 Erectile Dysfunction Drugs Production Mode & Process
13.2 Erectile Dysfunction Drugs Sales Channels Analysis
13.2.1 Direct Comparison with Distribution Share
13.2.2 Erectile Dysfunction Drugs Distributors
13.2.3 Erectile Dysfunction Drugs Customers
14 Concluding Insights
15 Appendix
15.1 Reasons for Doing This Study
15.2 Research Methodology
15.3 Research Process
15.4 Authors List of This Report
15.5 Data Source
15.5.1 Secondary Sources
15.5.2 Primary Sources
15.6 Disclaimer
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.